Drugmaker Growth: The China Connection
240121
Drugmakers get part of the job done outside of the U.S.
458562
Research and Markets (http://www.researchandmarkets.com/reports/c46817)  has announced the addition of Chinese Markets for Detergent to their  offering.  China's demand for detergent chemicals has grown at a fast pace in the  past decade.
103886
How the Bureau of Labor Statistics compiles data on pharmaceutical prices.
97570
Drug companies are becoming less innovative, with the number of new drugs being developed failing to keep pace  with the substantial increases in spending on research and development, according to congressional investigators.
738382
The drug maker is poised to speed past its rivals.
503597
SINGAPORE: Singapore manufacturing output growth slowed to 5.3 percent in August from 19.1 percent in July due to a sharp contraction in pharmaceuticals production, the government says.
254969
CEOs in the life-sciences business are supposed to be sober, scientifically grounded leaders. So, when Josh Boger, chief executive of Vertex Pharmaceuticals Inc. , showed a slide last year comparing one of the drugs his Cambridge company is developing to Apple's iPod, he raised a lot of eyebrows.
434277
The market might overlook the drug maker's promising programs.
710659
SHANGHAI -- Hunched over clattering machinery, the 170 workers at a factory here churn out gleaming pistons for auto engines by the crateful, driven by surging demand from abroad. To hear managers at Shanghai Datong Automotive Industrial Co. tell it, their success overseas is due to efficiency and...
640850
SHANGHAI -- Looking at the facts, the past year seems to have been disastrous for Worldbest Pharmaceutical.  First, there were reports of accounting irregularities and exaggerated profit. Half the managers were fired. Then, in the summer, six people died and at least 80 fell ill after receiving an...
75091
The world's largest generics maker continues to post strong growth by bedeviling Big Pharma.
20326
When a great launch of a good drug is not enough.
82904
SHANGHAI -- Looking at the facts, the past year seems to have been disastrous for Worldbest Pharmaceutical.  First, there were reports of accounting irregularities and exaggerated profit. Half the managers were fired. Then, in the summer, six people died and at least 80 fell ill after receiving an antibiotic injection manufactured by a subsidiary. Most recently, the company warned investors that it was likely to report its third consecutive year of losses....
147168
The approval of a new drug is a long-term opportunity.
21611
One undervalued drug developer may be on the cusp of greatness.
266608
The Motley Fool - Smaller drug developers like Cubist Pharmaceuticals (Nasdaq: CBST - News) don't have nearly the level of resources needed to bring their drugs to market and commence sales in the fragmented pharmaceutical marketplace throughout much of the world. The only way for specialty pharmas like Cubist to get their drugs to countries outside the United States or the European Union is by teaming with a much larger pharmaceutical company. ...
562473
The drugmaker announces another great quarter of growth.